# OnCo record paper-hpv-vaccine-england-lancet-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-hpv-vaccine-england-lancet-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-hpv-vaccine-england-lancet-2021" ;
  schema:name "England's HPV programme: cervical cancer down 87% in the first cohort vaccinated at 12-13"@en ;
  schema:description "Ten years after England began vaccinating 12- to 13-year-olds with the bivalent HPV vaccine, cervical cancer in that cohort had fallen by 87% and severe precancer (CIN3) by 97%."@en ;
  schema:url <https://onco.cc/key-papers/paper-hpv-vaccine-england-lancet-2021/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(21)02178-4> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(21)02178-4> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Falcaro M, Castañon A, Ndlela B, et al." ;
  onco:related <https://onco.cc/key-papers/paper-hpv-vaccine-sweden-nejm-2020/>, <https://onco.cc/ideas/idea-prev-hpv-vaccinate-at-screening/>, <https://onco.cc/ideas/idea-prev-hpv-male-catchup-oropharynx/> ;
  onco:cancers <https://onco.cc/cancers/cervical/> ;
  onco:sections <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/technologies/hpv-vaccine/>, <https://onco.cc/technologies/hpv-testing/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-prevention-adoption/>, <https://onco.cc/bottlenecks/b-global-access/> ;
  onco:journals <https://onco.cc/journals/lancet/> .